Home › GenMark Diagnostics Reports 64 Percent Rise in Q2 Revenues

GenMark Diagnostics Reports 64 Percent Rise in Q2 Revenues

Jul 28, 2016

NEW YORK (GenomeWeb) – GenMark Diagnostics reported after the close of the market on Thursday that its second quarter revenues rose 64 percent, driven by strength in sales of its XT-8 eSensor molecular diagnostics system and its infectious disease menu.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Dec
12
Featured Webinar

Precision Metagenomics to Identify Patients at Risk for Invasive Infection

This webinar will discuss the use of shotgun metagenomics to identify children at risk of hospital-acquired infection.

What's Popular?

In Molecular Diagnostics

  1. Guardant Health to Launch Cell-Free DNA Assay for Cancer Recurrence Monitoring in 2019

    Premium

  2. Legislators Release New Draft Bill Incorporating FDA Ideas for Diagnostics Regulation

  3. SABCS 2018 Features Molecular Diagnostics Research

  4. Novacyt to Sell Cytology, Clinical Lab Units

  5. PredictImmune Gains CE-IVD Mark for IBD Test

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2018 GenomeWeb LLC.  All Rights Reserved.